Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
5 hedge funds and large institutions have $22.2K invested in Vaxart in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 13 closing their positions.
1.02% less ownership
Funds ownership: 1.02% → 0% (-1%)
71% less funds holding
Funds holding: 17 → 5 (-12)
92% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 13
97% less capital invested
Capital invested by funds: $840K → $22.2K (-$818K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KWA
Kingswood Wealth Advisors
San Diego,
California
|
+$3.47K |
| 2 |
HWA
Heritage Wealth Advisors
Richmond,
Virginia
|
+$1.39K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$703K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$34.4K |
| 3 |
HSA
HBK Sorce Advisory
Erie,
Pennsylvania
|
-$26.2K |
| 4 |
BCMLT
Beacon Capital Management LLC (Tennessee)
Franklin,
Tennessee
|
-$22K |
| 5 |
CFO
Custos Family Office
Austin,
Texas
|
-$18.2K |
VXRT Hedge Fund Activity: Q4 2025 in Review
5 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2025, worth a combined $22.2K — down 97% from $840K a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of VXRT and 1 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Kingswood Wealth Advisors, opening a new position worth an estimated $3.47K. The largest seller was Marshall Wace, exiting entirely with an estimated $703K sold.
- 5 institutional investors held Vaxart (VXRT) as of Q4 2025, down from 17 in Q3 2025.
- Funds reported $22.2K of Vaxart stock for Q4 2025, down 97% quarter-over-quarter.
- 1 fund opened new Vaxart positions in Q4 2025 and 13 closed out, a net change of -12 holders.
- The largest Vaxart buyer in Q4 2025 was Kingswood Wealth Advisors, an estimated $3.47K added.
- The largest Vaxart seller in Q4 2025 was Marshall Wace, an estimated $703K sold.
Based on aggregated 13F filings for Q4 2025.